CH EPL (R5)
0.1.0 - ci-build
CH EPL (R5)
0.1.0 - ci-build
CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition Entocort-Solvent-and-Tablet
CH - SMC Authorized Dose Form: Tablet and solvent for rectal suspension
CH - EPL Full Limitation Text: Distale Form der Colitis ulcerosa bei ungenügendem Ansprechen auf oder Kontraindikation für Mesalazin.
identifier: http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID/CH-7601001346451-5204201
domain: Human
combinedPharmaceuticalDoseForm: Tablet and solvent for rectal suspension
indication:
Leichte bis mittelschwere Colitis ulcerosa des Rectums sowie des Colon sigmoideum.
legalStatusOfSupply: Abgabe auf ärztliche oder tierärztliche Verschreibung (B)
additionalMonitoringIndicator: No Warning
pediatricUseIndicator: Zugelassen für die Anwendung bei Kindern
classification: budesonide, NA BWS Art 12. Abs. 5 VAZV, Synthetika, Originalpräparat
attachedDocument:
name
productName: ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk
type: Zugelassener Arzneimittelname
Usages
Country Language Switzerland German (Switzerland)